No Record Found
Sector
HealthcareOpen
₹641.8Prev. Close
₹642.35Turnover(Lac.)
₹2,226Day's High
₹646.65Day's Low
₹635.2552 Week's High
₹67552 Week's Low
₹387.1Book Value
₹74.13Face Value
₹10Mkt Cap (₹ Cr.)
33,056.12P/E
102.37EPS
6.23Divi. Yield
0.7625 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
30 Jul 2025
12:00 AM
AGM
Announcement Date: 30 Jul, 2025
20 May 2025
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 28 Aug, 2025
For the quarter ended June 30, 2025, Aster reported a consolidated revenue of ₹1,078 crore. This is up 8% from ₹1,002 crore in the same period last year.
EBITDA increased 20.3% to ₹191.7 crore in the March 2025 quarter from ₹159.4 crore a year ago.
Over the next 5 years (FY25-FY29), the India business is expected to grow at a CAGR of approximately 18% - 20% YoY.
This project aims to improve medical outcomes and access to quality care in Hyderabad and nearby areas.
Here are some of the stocks that may see significant price movement today: HFCL, Aster DM Healthcare, Tata Steel, Glenmark Pharma, etc.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 499.52 | 499.52 | 499.52 | 499.52 |
Preference Capital | 374.38 | 374.38 | 374.38 | 374.38 |
Reserves | 2,465.59 | 2,420.34 | 2,256.66 | 2,081.31 |
Net Worth | 3,339.49 | 3,294.24 | 3,130.56 | 2,955.21 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,116.47 | 746.54 | 760.42 | 530.06 |
yoy growth (%) | 49.55 | -1.82 | 43.45 | 39.67 |
Raw materials | -273.54 | -185.88 | -186.26 | -147.83 |
As % of sales | 24.5 | 24.89 | 24.49 | 27.88 |
Employee costs | -172.09 | -143.78 | -130.42 | -106.07 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 89.96 | -68.04 | 64.61 | -87.19 |
Depreciation | -98.72 | -95 | -89.32 | -59.07 |
Tax paid | 0.22 | -0.74 | -4 | 0 |
Working capital | 21.48 | -9.48 | -261.2 | 105.73 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 49.55 | -1.82 | 43.45 | 39.67 |
Op profit growth | 259.78 | -42.39 | 646.27 | -120.6 |
EBIT growth | -524.79 | -132.24 | -394.27 | -60.5 |
Net profit growth | -231.11 | -213.47 | -169.51 | -286.68 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 4,138.46 | 3,698.9 | 2,994.05 | 10,253.28 | 8,608.43 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 4,138.46 | 3,698.9 | 2,994.05 | 10,253.28 | 8,608.43 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 5,219.43 | 31.73 | 352.8 | 51.2 | 53.49 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,180.7 | 150.22 | 1,14,795.68 | 166.03 | 0.13 | 694.02 | 85.26 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,929 | 84.34 | 1,13,985.29 | 306.9 | 0.16 | 2,167.9 | 607.44 |
Fortis Healthcare Ltd FORTIS | 967.15 | 415.13 | 73,023.33 | 51.88 | 0.1 | 433.03 | 120.19 |
Global Health Ltd MEDANTA | 1,370.6 | 73.28 | 36,753.05 | 151.96 | 0 | 882.16 | 130.12 |
Narayana Hrudayalaya Ltd NH | 1,782.4 | 84.29 | 36,414.03 | 87.37 | 0.25 | 943.14 | 107.01 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / M D / Promoter
Mandayapurath Azad Moopen
ED / Deputy MD / Promoter
Alisha Moopen
Non-Exec & Non-Independent Dir
Zeba Azad Moopen
Non-Exec & Non-Independent Dir
Anoop Moopen
Non-Exec & Non-Independent Dir
Thadathil Wilson
Non-Exec & Non-Independent Dir
Shamsudheen Bin Mohideen Mammu Haji
Independent Non Exe. Director
C J George
Independent Non Exe. Director
Mr. Emmanuel David Gootam
Independent Non Exe. Director
M Madhavan Nambiar
Independent Non Exe. Director
DEEPTI PURANA HOUSDURGAMVIJAYA
Independent Non Exe. Director
Sunil Theckath
Independent Non Exe. Director
James Mathew
Company Sec. & Compli. Officer
Hemish Purushottam
IX/475L Aster Medcity,
Kuttisahib Road Cheranalloore,
Kerala - 682027
Tel: 91-0484-6699228
Website: http://www.asterdmhealthcare.com
Email: cs@asterdmhealthcare.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Aster DM Healthcare Limited was erstwhile established as Aster DM Healthcare Private Limited, a private limited company on 18 January, 2008. On November 29, 2013. The Company was converted into a publ...
Read More
Reports by Aster DM Healthcare Ltd
What is the Aster DM Healthcare Ltd share price today?
What is the Market Cap of Aster DM Healthcare Ltd?
What is the PE and PB ratio of Aster DM Healthcare Ltd?
What is the 52 Week High and Low of Aster DM Healthcare Ltd?
What is the CAGR of Aster DM Healthcare Ltd?
What is the shareholding pattern of Aster DM Healthcare Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
